Categories: News

NYSE Content Advisory: Pre-Market Update + BETA Technologies Raises Over $1 Billion in IPO

NEW YORK, Nov. 4, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 4th

- Advertisement -
  • Equities are pulling back early Tuesday after a run fueled by AI stocks. The S&P 500 added 0.2% Monday on the back of a 4% rally in shares of Amazon. The company inked a deal with OpenAI that sent it to a record close.
  • At a Summit in Hong Kong, Morgan Stanley’s Ted Pick and Goldman Sachs’ David Solomon warned of a double-digit pop after the S&P 500 surged more than 35% from its April lows.
  • Beta Technologies is set to debut on the NYSE today after pricing an upsized IPO at $34 each. The electric aircraft developed raised more than $1 billion by offering nearly 30 million shares. It will trade under the ticker symbol BETA.


Opening Bell


Beta Technologies (NYSE: BETA) celebrates its initial public offering

- Advertisement -


Closing Bell


Capital Group celebrates the 3-year anniversary of the launch of CGMS, CGMU and CGSD and the listing of its three newest ETFs – CGGG, CGVV and CGHY.

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2813192/NYSE_Market_Update_November_4.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5600792/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–beta-technologies-raises-over-1-billion-in-ipo-302604121.html

- Advertisement -

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

5 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

5 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

12 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

12 hours ago